Evaluation of multiple antibiotic resistance (MAR) index and Doxycycline susceptibility of Acinetobacter species among inpatients

References

1. Park SY, Choo JW, Kwon SH, Yu SN, Lee EJ, Kim TH et al. Risk Factors for Mortality in Patients with Acinetobacter baumanii Bacteremia. Infect Chemother 2013;45(3):325-330.
2. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005;11(11):868–
3. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008;197:1079-81.
4. Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A et al. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis. 2008;27(7):607-12.
5. Sivaranjani V, Umadevi S, Srirangaraj S, Kali A, Seetha KS. Multi drug resistant Acinetobacter species from various clinical samples in a tertiary care hospital from South India. AMJ. 2013;6(12):697-700.
6. Dash M, Padhi S, Pattnaik S, Mohanty I, Misra P. Frequency, risk factors, and antibiogram of Acinetobacter species isolated from various clinical samples in a tertiary care hospital in Odisha, India. Avicenna J Med. 2013;3(4):97–102.
7. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumanii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21(3):538-82.
8. Appleman.MD, Belzberg.H, Citron DN, Heseltine.PN, Yellin AE, Murray J et al. In vitro activities of nontraditional antimicrobials against Multiresistant Acinetobacter baumanii strains isolated in an intensive care unit outbreak. Antimicrob agents chemother 2000;44:1035–1040.
9. Osundiya OO, Oladele RO, Oduyebo OO. Multiple Antibiotic Resistance (MAR) Indices of Pseudomonas and Klebsiella species isolates in Lagos University Teaching Hospital. Afr . J. Cln. Exper. Microbiol 2013;14(3):164-168. Raminder Sandhu et al. Evaluation of multiple antibiotic resistance (MAR) index and Doxycycline…. Indian J Microbiol Res 2016;3(3):299-304 304
10. Okeke IN, Laxminarayan R., Bhutta ZA, Duse AG, Jenkins P, O’Brien TF et al. Antimicrobial resistance in developing countries. Part 1: recent trends and current status. The Lancet Inf. Dis. 2005.5:8;481-493.
11. Collee JG, Miles RS, Watt B. Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A (eds). Mackie and McCartney practical medical microbiology. 14th edn. Edinburgh: Churchill Livingstone. 1996;131–52
12. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disc method. American Journal of Clinical Pathology. 1966;45: 493–
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI Document M-100 S22. Wayne, Pennsylvania. Clinical and Laboratory Standards Institute. 2012;32(3).
14. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pan drug resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18(3):268-81.
15. Krumperman PH. Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Applied Environ. Microbiol 1983;46:165-170.
16. Jung JY, Park MS, Kim SE, Park BH, Son JY, Kim EY et al.: Risk factors for multi-drug resistant Acinetobacter baumanii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 2010;10:228.
17. Lahiri KK, Mani NS, Purai SS. Acinetobacter spp as Nosocomial Pathogen: Clinical Significance and Antimicrobial Sensitivity. MJAF 2004;60(1):7-10.
18. Sanjeev H., Swathi N., Asha Pai, Rekha R., Vimal K. & Ganesh H.R. Systematic Review of Urinary Tract infection caused by Acinetobacter species among hospitalized patients .NUJHS 2013;3(4):7-9.
19. Shrivastava G, Bhatambare GS, Bajpai T, Patel KB. Sensitivity profile of multidrug resistant Acinetobacter Spp. isolated at ICUs of tertiary care hospital. Int J Health Syst Disaster Manage 2013;1:200-3.
20. Joshi SG, Litake GM, Niphadkar KB and Ghole VS. Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital. J Infect Chemother 2003;9(2):187-190.
21. Baran G, Erbay A, Bodur H, Ongόrό P, Akinci E, Balaban N, et al. Risk factors for nosocomial Imipenem- resistant Acinetobacter baumannii infections. Int J Infect Dis 2008;12:16-21.
22. Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, Kim M. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Inf C Hosp Epidemiol 2009;30:1186-1192.
23. Muhammad Fayyaz, Inam Ullah Khan, Aamir Hussain, Irfan Ali Mirza, Shamshad Ali and Nauman Akbar. Frequency and Antimicrobial Susceptibility Pattern of Acinetobacter Species Isolated from Pus and Pus Swab Specimens. Journal of the College of Physicians and Surgeons Pakistan 2015, Vol.25(5):346-349.
24. Maleki MH, Sekawi Z, Suroush S, Jalilan FA, Asadollahi K, Mohammadi E, et al. Phenotypic and genotypic characteristics of tetracycline resistant Acinetobacter baumannii isolates from nosocomial infections at Tehran hospitals. Iran J Basic Med Sci. 2014;17:21-6.
25. Khan F, Siddiqui N, Shukla I, Shujatullah F. Doxycycline sensitivity in multidrug resistant Acinetobacter baumanii isolates from blood. Annals of Pathology and Laboratory Medicine. 2014;1(1):15-19.
26. Vila, J, Marcos A, Marco F, Abdalla S, Vergara Y, Reig J. In vitro antimicrobial production of β-lactamases, aminoglycoside modifying enzymes and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 1993;37:138–41.
27. Ehinmidu J.O. 2003. Antibiotic susceptibility patterns of urine bacterial isolates in Zaria, Nigeria. Trop. J. Pharm. Res. 2(2):223-228.